Lane Johnson's Return Is Great News — But the Eagles' O-Line Health Crisis Isn't Over

Lane Johnson is coming back. Landon Dickerson is expected to return. Cam Jurgens is rehabbing his back. On paper, the Philadelphia Eagles' offensive line is getting the band back together. In reality, the health concerns surrounding this group should terrify you.

Start with the big picture: the star of the Eagles' Super Bowl-era run has been the offensive line. It's been the foundation of everything — the run game, the play-action passing, the quarterback protection. And right now, that foundation has more cracks in it than at any point in the last five years.

Johnson, 36, is recovering from a Lisfranc injury that cost him the final eight games of 2025. The good news is that Lisfranc injuries, when properly healed, tend to resolve completely. The bad news is that Johnson is in double-digit surgeries for his career, and at his age, recovery takes longer and the margin for error is razor-thin.

The most confidence you can have in any of the three returning linemen is actually in Johnson. Not because he's the youngest — he's decidedly the oldest — but because his injury is the most straightforward. It heals or it doesn't. And it should be healed by September.

Dickerson is the bigger worry. His injury issues have been more chronic in nature, and that's a different animal entirely. A one-time acute injury is manageable. Recurring problems that compound over time are career-threatening. Dickerson's talent is undeniable, but his ability to stay on the field for 17 games plus playoffs is a genuine question mark.

Then there's Jurgens, who traveled to Medellín, Colombia for stem cell treatment on his back. That's not something a player does when conventional treatment is working. Going outside the normal medical channels suggests the injury is more serious than anyone has publicly acknowledged. If it works, great. If it doesn't, the Eagles are looking at a center position that could be compromised for the entire season.

Jeff Stoutland's departure adds another layer of concern. The offensive line coach who maximized this group's potential for over a decade is gone, replaced by Chris Kuper. The transition, even under the best circumstances, creates uncertainty. With three players dealing with significant health questions, the timing is brutal.

The Eagles need to invest in offensive line depth this offseason like their season depends on it — because it does. Banking on all three starters being healthy and productive is a gamble no smart organization should make. The draft needs to include at least one offensive lineman in the first three rounds, and free agency should target a veteran who can start if called upon.

The talent is there if the health cooperates. That's a big if. And "if" is a terrible foundation for a Super Bowl run.